Now showing items 1-2 of 2
Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005–15
(American Society of Health-System Pharmacists, 2017-07)
Purpose Overall and specific class trends in systemic antifungal expenditures in various U.S. healthcare settings from 2005 through 2015 were evaluated. Methods Systemic antifungal expenditures from January 1, 2005, ...
National trends in prescription drug expenditures and projections for 2018
(American Society of Health-System Pharmacists, 2018-05)
Purpose Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2018 in nonfederal hospitals, clinics, and overall (all sectors). Methods ...